Mr. Tontat is Kiromic’s Chief Financial Officer. Prior to joining Kiromic, Mr. Tontat worked as a business and financial consultant, raising funds, for private and public companies. Public companies include Sorrento Therapeutics (NASDAQ: SRNE) and NantKwest (NASDAQ: NK). Mr. Tontat previously worked as an investment analyst at healthcare-specific hedge funds in New York, and as an investment banker for HSBC Investment Bank, in their New York and Paris offices. Mr. Tontat earned his B.A. in Economics from Harvard University.